Sugar-Based Excipients Market Report 2026

The sugar-based excipients market size has grown steadily in recent years. It will grow from $1.49 billion in 2025 to $1.55 billion in 2026 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to growth in pharmaceutical manufacturing output, widespread use of lactose and sucrose excipients, expansion of generic drug production, increasing demand for solid oral dosage forms, established regulatory acceptance of sugar excipients.

The sugar-based excipients market size is expected to see steady growth in the next few years. It will grow to $1.81 billion in 2030 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to growing adoption of low-calorie and non-cariogenic excipients, rising demand for pediatric and geriatric formulations, expansion of biopharmaceutical production, focus on clean-label excipient sourcing, increasing investments in excipient innovation. Major trends in the forecast period include increasing use of sugar alcohol-based excipients, rising demand for patient-friendly formulations, growing adoption of multifunctional excipients, expansion of orally disintegrating dosage forms, enhanced focus on excipient purity standards.

The increasing demand for pharmaceutical products is anticipated to drive the growth of the sugar-based excipients market in the coming years. The pharmaceutical industry is centered on the research, development, manufacturing, and commercialization of medicines aimed at improving health outcomes. Pharmaceutical demand is rising due to the growing need for innovative therapies, advancements in drug development technologies, and expanding global healthcare requirements. In pharmaceutical formulations, sugar-based excipients function as fillers, binders, and stabilizers, improving formulation performance, taste, and bioavailability. For example, in August 2025, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade organization representing the pharmaceutical sector, health-related industries invested around $281.2 billion (€258.1 billion) in R&D in 2023, representing 20.5% of total global business R&D expenditure. Thus, the growing prominence of pharmaceuticals is fueling the expansion of the sugar-based excipients market.

Leading companies in the sugar-based excipients market are focusing on the development of innovative offerings, such as next-generation mannitol products, to improve drug stability, enhance solubility, and optimize formulation performance for pharmaceutical uses. These next-generation mannitol products are advanced formulations designed to strengthen drug stability, improve solubility, and support efficient tablet compression for improved pharmaceutical performance. For instance, in May 2023, Roquette, a France-based supplier of plant-based ingredients and pharmaceutical and nutraceutical excipients, launched PEARLITOL® ProTec, a co-processed mannitol-maize starch excipient, at Vitafoods Europe. The product features a controlled water activity (Aw) of less than 0.2 and moisture content below 1%, helping to stabilize probiotics and other moisture-sensitive active ingredients. It also offers excellent flowability and compactability, enabling its use in direct-compression tablets, stick packs, or sachets without the need for additional drying steps. Fully compliant with major pharmacopeial standards, the excipient is designed to support nutraceutical manufacturers in meeting strict stability and regulatory requirements more efficiently.

In October 2023, Roquette Freres, a France-based food company, acquired Qualicaps Inc. for an undisclosed sum. Through this acquisition, Roquette seeks to broaden its global presence in the pharmaceutical sector, integrate specialized expertise in hard capsules, strengthen its oral dosage solution portfolio, reinforce its position in pharmaceutical excipients, and offer customers a wider and more innovative range of products. Qualicaps Inc. is a US-based pharmaceutical company engaged in the design, manufacturing, and sale of capsules, including sugar-based excipients.

Major companies operating in the sugar-based excipients market are Cargill Incorporated, Archer Daniels Midland Company, Associated British Foods PLC, DuPont de Nemours Inc., IFF Pharmaceuticals Solutions, Ingredion Incorporated, Tereos S.A., Roquette Frères S.A., IMCD N.V., Ashland Global Holdings Inc., Tate & Lyle PLC, Colorcon Inc., DFE Pharma, Emilio Castelli S.R.L., Pfanstiehl Inc., Meggle AG, Scope Ingredients Pvt. Ltd., Citron Scientific, MB Sugars & Pharmaceuticals, Prinova Group LLC, Global Sweeteners Holdings LLC, CSM Ingredients.

North America was the largest region in the sugar-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sugar-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sugar-based excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the sugar-based excipients market by increasing costs of imported raw sugars, sugar alcohols, processing chemicals, and purification equipment used in excipient manufacturing. Pharmaceutical and food ingredient producers in North America and Europe are most affected due to reliance on imported specialty sugars, while Asia-Pacific faces export cost pressures. These tariffs are raising production costs and impacting pricing structures. However, they are also encouraging local sugar processing, regional excipient production, and diversification of raw material sourcing.

The sugar-based excipients market research report is one of a series of new reports that provides sugar-based excipients market statistics, including sugar-based excipients industry global market size, regional shares, competitors with a sugar-based excipients market share, detailed sugar-based excipients market segments, market trends and opportunities, and any further data you may need to thrive in the sugar-based excipients industry. This sugar-based excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sugar-based excipients are a class of pharmaceutical excipients obtained from sugars and their derivatives, including sucrose, lactose, glucose, sorbitol, and mannitol. These excipients are incorporated into drug formulations to serve multiple functions, enhancing the physical and chemical characteristics of medicines and improving patient compliance.

The main product types of sugar-based excipients include actual sugars, artificial sweeteners, and sugar alcohols. Actual sugars are natural carbohydrates such as sucrose, glucose, and lactose that are widely used in pharmaceutical formulations to improve taste, texture, and stability, thereby enhancing the palatability and effectiveness of medications. These excipients are classified by dosage form into liquid, semi-solid, and solid formulations. They are used in applications such as diluents, fillers, tonicity agents, and flavoring agents, and serve end users across the pharmaceutical, food and beverage, and cosmetics and personal care industries.

The sugar-based excipients market consists of sales of sucrose-based excipients, lactose-based excipients, and glucose-based excipients. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.